International Journal of Molecular Sciences,
Год журнала:
2022,
Номер
23(24), С. 15834 - 15834
Опубликована: Дек. 13, 2022
The
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
spike
protein
binds
to
the
cellular
receptor—angiotensin-converting
enzyme-2
(ACE2)
as
first
step
in
viral
cell
entry.
SARS-CoV-2
expression
ACE2-expressing
surface
induces
cell–cell
membrane
fusion,
thus
forming
syncytia.
To
exert
its
fusogenic
activity,
is
typically
processed
at
a
specific
site
(the
S1/S2
site)
by
proteases
such
furin.
C488
residue,
located
spike–ACE2
interacting
surface,
critical
for
and
infectious
roles
of
protein.
We
have
demonstrated
that
residue
involved
subcellular
targeting
processing.
mutant
localization
Golgi
apparatus
were
impaired.
Consequently,
processing
protein,
probed
anti-Ser-686-cleaved
antibody,
markedly
decreased
proteins.
Moreover,
brefeldin-A-mediated
endoplasmic-reticulum-to-Golgi
traffic
suppression
also
suppressed
As
brefeldin
A
treatment
mutation
inhibited
syncytia
formation,
required
functional
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2022,
Номер
unknown
Опубликована: Авг. 30, 2022
Neutralization
assays
are
experimental
surrogates
for
the
effectiveness
of
infection-
or
vaccine-elicited
polyclonal
antibodies
and
therapeutic
monoclonal
targeting
SARS-CoV-2.
However,
measured
neutralization
can
depend
on
details
assay.
Here
we
systematically
assess
how
ACE2
expression
in
target
cells
affects
by
to
different
spike
epitopes
lentivirus
pseudovirus
assays.
For
high
ACE2-expressing
cells,
receptor
binding
domain
(RBD)
account
nearly
all
neutralizing
activity
human
sera.
But
lower
regions
outside
RBD
make
a
larger
(although
still
modest)
contribution
serum
neutralization.
These
serum-level
results
mirrored
antibodies:
N-terminal
(NTD)
that
do
not
compete
incompletely
neutralize
but
completely
with
expression.
Our
show
level
is
an
important
variable,
emphasizes
role
subset
RBD-directed
antibodies.
PLoS Pathogens,
Год журнала:
2024,
Номер
20(8), С. e1012453 - e1012453
Опубликована: Авг. 15, 2024
Neutralization
of
Severe
Acute
Respiratory
Syndrome
Coronavirus
2
(SARS-CoV-2)
by
human
sera
is
a
strong
correlate
protection
against
symptomatic
and
severe
Disease
2019
(COVID-19).
The
emergence
antigenically
distinct
SARS-CoV-2
variants
concern
(VOCs)
the
relatively
rapid
waning
serum
antibody
titers,
however,
raises
questions
about
sustainability
protection.
In
addition
to
neutralization,
other
functionalities
memory
B
cell
(MBC)
response
are
suggested
help
maintaining
this
study,
we
investigate
breadth
spike
(S)
protein-specific
antibodies
that
mediate
effector
functions
interacting
with
Fc-gamma
receptor
IIa
(FcγRIIa)
FcγRIIIa,
binding
domain
(RBD)-specific
MBCs,
following
primary
infection
D614G,
Alpha,
Beta,
Gamma,
Delta,
Omicron
BA.1
or
BA.2
variant.
Irrespectively
variant
causing
infection,
S
interact
FcγRIIa
FcγRIIIa
RBD-specific
MBC
responses
exceeded
although
Alpha-induced
seemed
more
strain-specific.
Between
VOC
groups,
both
quantitative
qualitative
differences
in
immune
were
observed,
suggesting
immunogenicity.
Overall,
study
contributes
understanding
protective
humoral
light
emerging
VOCs,
highlights
need
system
beyond
neutralization
gain
better
variants.
Proceedings of the National Academy of Sciences,
Год журнала:
2024,
Номер
121(43)
Опубликована: Окт. 14, 2024
Although
it
is
well
established
that
the
SARS-CoV-2
spike
glycoprotein
binds
to
host
cell
ACE2
receptor
initiate
infection,
far
less
known
about
tissue
tropism
and
susceptibility
virus.
Differential
expression
across
different
types
of
heparan
sulfate
(HS)
proteoglycans,
with
variably
sulfated
glycosaminoglycans
(GAGs),
their
synergistic
interactions
viral
N-glycans
may
contribute
susceptibility.
Nevertheless,
contribution
remains
unclear
since
HS
evade
experimental
characterization.
We,
therefore,
carried
out
microsecond-long
all-atom
molecular
dynamics
simulations,
followed
by
random
acceleration
fully
glycosylated
spike:ACE2
complex
without
highly
GAG
chains
bound.
By
considering
model
GAGs
as
surrogates
for
expressed
in
lung
cells,
we
identified
key
entry
mechanisms
SARS-CoV-2.
We
find
promotes
structural
energetic
stabilization
active
conformation
receptor-binding
domain
(RBD)
reorientation
toward
N-terminal
same
subunit
RBD.
Spike
exert
effects,
promoting
better
packing,
strengthening
protein:protein
interaction,
prolonging
residence
time
complex.
binding
trigger
rearrangement
S2’
functional
protease
cleavage
site
through
allosteric
interdomain
communication.
These
results
thus
show
has
a
multifaceted
role
facilitating
they
provide
mechanistic
basis
development
derivatives
anti-SARS-CoV-2
potential.
American Journal of Tropical Medicine and Hygiene,
Год журнала:
2023,
Номер
109(4), С. 890 - 894
Опубликована: Авг. 14, 2023
Determination
of
previous
SARS-COV-2
infection
is
hampered
by
the
absence
a
standardized
test.
The
marker
used
to
assess
exposure
IgG
antibody
nucleocapsid
(IgG
anti-N),
although
it
known
wane
quickly
from
peripheral
blood.
accuracies
seven
tests
(virus
neutralization
test,
anti-N,
anti-spike
[anti-S],
anti-receptor
binding
domain
[anti-RBD],
anti-N
+
anti-RBD,
anti-S,
and
anti-S
anti-RBD),
either
singly
or
in
combination,
were
evaluated
on
502
cryopreserved
serum
samples
collected
before
COVID-19
vaccination
rollout
Kumasi,
Ghana.
accuracy
each
index
test
was
measured
using
composite
reference
standard
based
combination
tests.
According
reference,
262
participants
previously
exposed;
most
sensitive
virus
with
95.4%
sensitivity
(95%
CI:
93.6-97.3),
followed
79.0%
for
76.3-83.3).
specific
both
100%
specificity.
Viral
overall
accurate
tests,
specificity/sensitivity
100/95.2%
79.0/92.1%,
respectively.
Our
findings
indicate
that
alone
an
inadequate
prior
SARS
COV-2
this
population.
Virus
assay
appears
be
discerning
infection.
A
also
suited
assessment
low-resource
settings.
International Journal of Molecular Sciences,
Год журнала:
2022,
Номер
23(24), С. 15834 - 15834
Опубликована: Дек. 13, 2022
The
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
spike
protein
binds
to
the
cellular
receptor—angiotensin-converting
enzyme-2
(ACE2)
as
first
step
in
viral
cell
entry.
SARS-CoV-2
expression
ACE2-expressing
surface
induces
cell–cell
membrane
fusion,
thus
forming
syncytia.
To
exert
its
fusogenic
activity,
is
typically
processed
at
a
specific
site
(the
S1/S2
site)
by
proteases
such
furin.
C488
residue,
located
spike–ACE2
interacting
surface,
critical
for
and
infectious
roles
of
protein.
We
have
demonstrated
that
residue
involved
subcellular
targeting
processing.
mutant
localization
Golgi
apparatus
were
impaired.
Consequently,
processing
protein,
probed
anti-Ser-686-cleaved
antibody,
markedly
decreased
proteins.
Moreover,
brefeldin-A-mediated
endoplasmic-reticulum-to-Golgi
traffic
suppression
also
suppressed
As
brefeldin
A
treatment
mutation
inhibited
syncytia
formation,
required
functional